Brief: Cleo Diagnostics Appoints Hcfocus To Support Commencement Of Its U.S. Market Access Program
April 2 (Reuters) - Cleo Diagnostics Ltd COV.AX :
* CO APPOINTED HCFOCUS TO SUPPORT COMMENCEMENT OF ITS U.S.
MARKET
ACCESS PROGRAM
Further company coverage: COV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsBrief: Cleo Diagnostics Raises A$5M
Brief: Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising Announcement
Brief: Cleo Diagnostics Says Partnership With Entityrisk
Australia's Cleo Diagnostics rises to near 2-month high on US approval for trial
Australia's Cleo Diagnostics jumps on US clinical trials for cancer blood test